Muhammad Zeeshan Ghani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Zeeshan Ghani has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Zain Ul Abedeen
Department of medicine, Saidu Medical College, Swat, Pakistan
3 shared publications - Abad Ur Rehman
Department of Medicine Spinghar University (Kabul Campus) Kabul Afghanistan
2 shared publications - Abdullah Jan
Department of Gastroenterology Saidu Medical College Swat Pakistan
1 shared publication - Amna Raza
Akhtar Saeed Medical and Dental College, Lahore, Pakistan
1 shared publication - Bisma Tariq
Fatima Jinnah Medical University Lahore Pakistan
1 shared publication - Hafiz Umar Sohaib
Services Institute of Medical Sciences, Lahore, Pakistan
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (11)
Acute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan
Esophageal squamous cell carcinoma (ESCC) is exceptionally rare in children and adolescents and typically presents with progressive dysphagia and weight loss. Its occurrence without conventional risk factors may pose a diagnostic challenge. A 16‐year‐old boy presented with acute hematemesis and no history of dysphagia, odynophagia, or recognized esophageal cancer risk factors. He was undernourished, with a BMI of 17 kg/m 2 and progressive unquantified weight loss. Upper gastrointestinal endoscopy revealed a deep proximal esophageal ulcer, distal esophageal ulcers, a Mallory‐Weiss tear, and gastritis. The latter lesions offered potential explanations for the bleeding, but the atypical proximal ulcer raised suspicion for malignancy, prompting biopsy. Histopathology confirmed moderately differentiated ESCC with high‐grade dysplasia. Contrast‐enhanced CT showed localized upper thoracic esophageal wall thickening without regional lymphadenopathy or distant metastases, and the disease was staged as T2N0M0. The patient completed three cycles of neoadjuvant carboplatin‐paclitaxel‐based chemotherapy followed by radiotherapy. A repeat endoscopy showed a circumferential raw mucosal area with a superficial erosion in the distal esophagus, while the upper and middle thirds of the esophagus appeared normal; however, esophagectomy was recommended as part of the planned definitive management. This case highlights the incidental discovery of ESCC during evaluation of acute hematemesis in an adolescent without conventional risk factors. Hematemesis with low BMI or unexplained weight loss should prompt careful evaluation for underlying esophageal pathology, even when an apparent benign bleeding source is identified. Early biopsy, appropriate staging, and multidisciplinary management are essential for timely diagnosis and treatment.
- 10 November 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (11)
Open AccessAcute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan
Esophageal squamous cell carcinoma (ESCC) is exceptionally rare in children and adolescents and typically presents with progressive dysphagia and weight loss. Its occurrence without conventional risk factors may pose a diagnostic challenge. A 16‐year‐old boy presented with acute hematemesis and no history of dysphagia, odynophagia, or recognized esophageal cancer risk factors. He was undernourished, with a BMI of 17 kg/m 2 and progressive unquantified weight loss. Upper gastrointestinal endoscopy revealed a deep proximal esophageal ulcer, distal esophageal ulcers, a Mallory‐Weiss tear, and gastritis. The latter lesions offered potential explanations for the bleeding, but the atypical proximal ulcer raised suspicion for malignancy, prompting biopsy. Histopathology confirmed moderately differentiated ESCC with high‐grade dysplasia. Contrast‐enhanced CT showed localized upper thoracic esophageal wall thickening without regional lymphadenopathy or distant metastases, and the disease was staged as T2N0M0. The patient completed three cycles of neoadjuvant carboplatin‐paclitaxel‐based chemotherapy followed by radiotherapy. A repeat endoscopy showed a circumferential raw mucosal area with a superficial erosion in the distal esophagus, while the upper and middle thirds of the esophagus appeared normal; however, esophagectomy was recommended as part of the planned definitive management. This case highlights the incidental discovery of ESCC during evaluation of acute hematemesis in an adolescent without conventional risk factors. Hematemesis with low BMI or unexplained weight loss should prompt careful evaluation for underlying esophageal pathology, even when an apparent benign bleeding source is identified. Early biopsy, appropriate staging, and multidisciplinary management are essential for timely diagnosis and treatment.
- Open Access
- 7 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (32) , e50088
Mixed phenotype acute leukemia mimicking adult-onset Still’s disease in a pregnant female: A rare case report
Introduction: Mixed phenotype acute leukemia (MPAL) is an uncommon hematologic malignancy characterized by the coexistence of lymphoid and myeloid lineage markers. Although adult-onset Still’s disease (AOSD) is a diagnosis of exclusion, MPAL may rarely present with similar laboratory and clinical findings, resulting in delayed diagnosis and treatment. Case presentation: We report a case of a 36-year-old woman who presented at 20 weeks of gestation with inflammatory polyarthritis, hyperferritinemia, lymphadenopathy, thrombocytopenia, and leukocytosis. The patient fulfilled the Yamaguchi criteria for AOSD after exclusion of autoimmune and infectious conditions and was initially treated with hydroxychloroquine and corticosteroids. An inefficient response to treatment and persistent cytopenias led to reevaluation. A repeat peripheral smear revealed blast cells, and flow cytometry confirmed MPAL. Gestation-compatible chemotherapy protocols resulted in a favorable clinical and hematologic response, with no adverse maternal or fetal outcomes. Clinical discussion: The clinical overlap between the manifestations of AOSD and MPAL may occasionally result in misdiagnosis and delayed detection of an underlying malignancy. In patients presenting with presumed AOSD, careful exclusion of hematologic cancers is essential, particularly in the presence of atypical features such as persistent systemic inflammation, cytopenias, or poor therapeutic response. Conclusion: This case describes a rare association between the manifestations of AOSD and MPAL. In addition, it highlights the importance of recognizing warning signs that may indicate an underlying malignancy in patients presenting with AOSD-like symptoms.
- 7 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (32) , e50088
Open AccessMixed phenotype acute leukemia mimicking adult-onset Still’s disease in a pregnant female: A rare case report
Introduction: Mixed phenotype acute leukemia (MPAL) is an uncommon hematologic malignancy characterized by the coexistence of lymphoid and myeloid lineage markers. Although adult-onset Still’s disease (AOSD) is a diagnosis of exclusion, MPAL may rarely present with similar laboratory and clinical findings, resulting in delayed diagnosis and treatment. Case presentation: We report a case of a 36-year-old woman who presented at 20 weeks of gestation with inflammatory polyarthritis, hyperferritinemia, lymphadenopathy, thrombocytopenia, and leukocytosis. The patient fulfilled the Yamaguchi criteria for AOSD after exclusion of autoimmune and infectious conditions and was initially treated with hydroxychloroquine and corticosteroids. An inefficient response to treatment and persistent cytopenias led to reevaluation. A repeat peripheral smear revealed blast cells, and flow cytometry confirmed MPAL. Gestation-compatible chemotherapy protocols resulted in a favorable clinical and hematologic response, with no adverse maternal or fetal outcomes. Clinical discussion: The clinical overlap between the manifestations of AOSD and MPAL may occasionally result in misdiagnosis and delayed detection of an underlying malignancy. In patients presenting with presumed AOSD, careful exclusion of hematologic cancers is essential, particularly in the presence of atypical features such as persistent systemic inflammation, cytopenias, or poor therapeutic response. Conclusion: This case describes a rare association between the manifestations of AOSD and MPAL. In addition, it highlights the importance of recognizing warning signs that may indicate an underlying malignancy in patients presenting with AOSD-like symptoms.
- Open Access
- 1 August 2026
- Published by Wiley in VIEW Medicine
- Vol. 1 (1) , e70004
Three‐Dimensionally Bioprinted Renal Organoids‐on‐a‐Chip for Personalized Prediction of Cyclosporine Nephrotoxicity in Rare Genetic Tubulopathies
- 1 August 2026
- Published by Wiley in VIEW Medicine
- Vol. 1 (1) , e70004
Open AccessThree‐Dimensionally Bioprinted Renal Organoids‐on‐a‐Chip for Personalized Prediction of Cyclosporine Nephrotoxicity in Rare Genetic Tubulopathies
- 29 June 2026
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 32 (6) , e227
Microbiome Dysbiosis as a Potential Driver of Inflammatory Mimicry in Pachydermoperiostosis-associated Hypertrophic Osteoarthropathy
- 29 June 2026
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 32 (6) , e227
Microbiome Dysbiosis as a Potential Driver of Inflammatory Mimicry in Pachydermoperiostosis-associated Hypertrophic Osteoarthropathy
- 29 May 2026
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (7) , 2218-2219
Re‐Evaluating the J‐GESS Score : A 5‐Year Unified Risk Prediction Model for Gastric Cancer and Esophageal Squamous Cell Carcinoma
- 29 May 2026
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (7) , 2218-2219
Re‐Evaluating the J‐GESS Score : A 5‐Year Unified Risk Prediction Model for Gastric Cancer and Esophageal Squamous Cell Carcinoma